Abstract:Background: Epilepsy during recombinant human growth hormone (rhGH) therapy is rare in children. The potential association between rhGH treatment and epilepsy remains unclear. Methods: We retrospectively analyzed the clinical data of two Chinese boys who experienced epilepsy during the use of rhGH and reviewed the relevant literature. Results: Case 1, an 8-year and 2-month-old boy, was diagnosed with short stature, malnutrition, and congenital hypothyroidism. He was on levothyroxine sodium tablets for a long time. Recurrent febrile convulsions were present at 6-7 years. Electroencephalogram and magnetic resonance imaging (MRI) showed no abnormality, and no treatment was given. He was diagnosed with complex febrile convulsions. The boy started rhGH treatment (approximately 0.15 IU/kg/day, sc, qd) at 8 years and 4 months. Epilepsy occurred three times during the 6 months of rhGH treatment. Electroencephalography confirmed a definitive diagnosis of epilepsy. Then, he discontinued rhGH treatment at 8 years and 11 months and started taking levetiracetam (0.25 g, po, bid) for antiepileptic therapy. Epilepsy was well-controlled 4 months later. He continued rhGH treatment at 10 years and 3 months and has been on rhGH treatment until now, with no recurrence of epilepsy. He has been taking levetiracetam to date. Case 2, a 9-year and 1-month-old boy, was diagnosed with central precocious puberty, predicted short final height, and overweight. He started treatment with triptorelin (3.75 mg, im, q4w) and rhGH (approximately 0.15 IU/kg/day, sc, qd) at 9 years and 3 months. He tended to fall repeatedly when he was approximately 10 years old. Electroencephalography showed a few medium- to high-amplitude sharp waves and sporadic sharp slow waves in the left middle temporal region, sometimes involving the left posterior temporal region. He was diagnosed with epilepsy. Triptorelin discontinuance provided no symptom relief, which worsened further. Subsequently, he withdrew from rhGH treatment, and the symptoms occurred occasionally within a week and stopped after 15 days. The electroencephalogram returned to normal. No further seizures occurred during follow-up to date. Conclusion: During the use of rhGH in short-stature children with complex febrile convulsions or underlying lesions related to neurological impairment or those being treated with antiepileptic drugs, epilepsy may be induced.

Epilepsy, depression, and growth hormone

Association of growth hormone deficiency (GHD) with anxiety and depression: experimental data and evidence from GHD children and adolescents

Case report: Epilepsy during the use of recombinant human growth hormone: a report on two cases and a literature review

Depression and anxiety in children and adolescents with epilepsy: Prevalence, risk factors, and treatment

Human sexuality, sex hormones, and epilepsy

Depression in Persons With Epilepsy

Current and Emerging Drug Therapies for the Treatment of Depression in Adults with Epilepsy

Depression in Persons With Epilepsy: Lessons From Case Review

Prevalence and Risk Factors of Anxiety and Depression in Adult Patients with Epilepsy: a Multicenter Survey-Based Study.

Reduced serum neurotrophic factors and monoamine neurotransmitters in epilepsy patients with comorbid depression

The Role of Adult Hippocampal Neurogenesis in Epilepsy and Comorbidities

Translocation of High Mobility Group Box 1 from the Nucleus to the Cytoplasm in Depressed Patients with Epilepsy

Mood disorders in adults with epilepsy: a review of unrecognized facts and common misconceptions

Treatment of depression in patients with epilepsy: problems, pitfalls, and some solutions

Depression and epilepsy: do glucocorticoids and glutamate explain their relationship?

The impact of epilepsy on the adolescent adolescent

Clinical Risk Factors for Depressive Symptoms in Patients with Epilepsy

Hypothalamic hamartoma with epilepsy: Review of endocrine comorbidity

Relationship between depression and sex steroid hormone among women with epilepsy

Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta

Increased Ratio of Glutamate/glutamine to Creatine in the Right Hippocampus Contributes to Depressive Symptoms in Patients with Epilepsy